Yemaachi Biotechnology
Yemaachi Biotechnology, based in Accra, Ghana, is an early-stage company focusing on precision cancer diagnostics and therapeutics across Africa, leveraging the continent's genetic diversity to build a comprehensive cancer knowledgebase.
Company Locations
Yemaachi Biotechnology operates in multiple locations to support its mission of diversifying and expanding access to precision cancer diagnostics and therapeutics. The company is based in Accra, Greater Accra Region, Ghana, with additional locations in Washington DC, USA, and Nairobi, Kenya. These strategic locations enable Yemaachi to collect and sequence a wide array of samples from across Africa, leveraging the continent's genetic diversity to build a robust clinical and molecular knowledge base.
Team Size and Structure
Yemaachi Biotechnology has a dedicated team of 16 professionals committed to advancing precision oncology. The team encompasses expertise in various scientific and operational disciplines, focusing on diversifying and improving cancer diagnostics. Based in Accra, the team works collaboratively with partners and collaborators from different sectors globally to achieve its mission.
Yemaachi Biotechnology in Y Combinator
Yemaachi Biotechnology was part of the Y Combinator S21 batch, gaining valuable support and mentorship from one of the world's leading startup accelerators. Participation in YC S21 provided Yemaachi with the resources and networks needed to scale its operations, execute its vision, and attract significant interest from investors and partners in the healthcare diagnostics sector.
Commitment to Cancer Diagnostics in Africa
Yemaachi Biotechnology's mission is to transform precision oncology by focusing on the African population's genetic diversity. By collecting and sequencing samples across the continent, the company is pioneering clinical genomic research for various cancer types. Yemaachi is building the world's most comprehensive cancer knowledge base, aiming to develop next-generation cancer drugs that are more effective in diverse populations.
Global Partnerships and Collaborations
Yemaachi Biotechnology is supported by a robust network of partners and collaborators across the public, private, and non-profit sectors globally. These partnerships are crucial for the company’s initiatives to diversify and expand access to precision cancer diagnostics and therapeutics. Collaborations help Yemaachi in research, development, and the implementation of innovative scientific solutions, ensuring a comprehensive approach to improving cancer treatment outcomes.